Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion
| Image |  |
|---|---|
| Description | scientific article published in May 2004 |
| Author/s |
author: Mario Sznol |
| Publication date | May 1, 2004 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |